NCT03907852 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT03907852
Title	Phase 1/2 Trial of Gavo-cel (TC-210) in Patients With Advanced Mesothelin-Expressing Cancer
Recruitment	Active, not recruiting
Gender	both
Phase	Phase Ib/II
Variant Requirements	No
Sponsors	TCR2 Therapeutics
Indications	peritoneal mesothelioma cholangiocarcinoma malignant pleural mesothelioma ovary serous adenocarcinoma lung non-small cell carcinoma
Therapies	Gavocabtagene autoleucel + Ipilimumab + Nivolumab Gavocabtagene autoleucel + Nivolumab Gavocabtagene autoleucel Cyclophosphamide + Fludarabine
Age Groups:	adult \| senior
Covered Countries	USA \| CAN

NCT03907852
Clinical Trial Detail